Sex drive is a serious matter with problematic facets nowadays, as the highly stressful circumstances we’re used to calling our daily routine seem to swallow all our lust for life. Or sex. In the case of men, scientists and researchers have developed the famous Viagra that boosts sexual appetite and capabilities, making detachment from the burden of routine possible, thus making men happier.
Well, for women, things are always foggier, more complex, more complicated, more emotional and harder to break through. Such is the case with the female drug correspondent for Viagra, which becomes more and more controversial as the US Food and Drug Administration finds that it has too many side effects. Not surprising at all, as women usually come with side effects, by their nature. Why should a drug designed to boost female sexual appetite be different from the natural way things go in the feminine realm?
Flibanserin, the pill aimed at restoring lost libido in women, has been evaluated in three phase-three clinical trials and was twice rejected by the FDA. It appears that Flibanserin has produced positive results in all three trials by now, which should have made it available over the counter, for all the women who still want to taste the little pleasures in life.
The FDA still rejects its release, though, because it caused a number of pretty dangerous side effects in some analyzed patients. The effects include nausea, dizziness and fainting, when combined with other drugs or alcohol and high blood pressure, as official reports reveal.
FDA rejection has caused serious controversy among women who are tired of living lives unburdened by desire. A campaign backed by the drug’s developer and some women’s groups accuse the FDA of gender bias for approving Viagra and 25 other drugs designed to boost appetite in men, while not a single prescription drug addressed to women’s libido hasn’t yet been released.
More than 40.000 signatures were gathered for this campaign that promotes gender equality that should be the standard when it comes to access treatments for sexual dysfunctions in particular.
However, this never ending debate of Flibanserin, the drug that belongs to Sprout Pharmaceutical, illustrates the very complex nature, politics and science that surround women’s sexuality. So from this point of view only, equality is not that equal, as the male anatomy seems to be simpler and less exposed to biologic variables, as menstruation for women. This could be the reason there isn’t yet any drug to boost sexual desire in women. But looking at the full half of the glass, there will always be a good man and a Viagra pill that can almost naturally make women’s life enjoyable again.
Image Source: stuff.co.nz
Leave a Reply
You must be logged in to post a comment.